Differentiating head and neck small-diameter lentigo maligna and lentigo maligna melanoma from challenging solar lentigines: A retrospective study - 15/05/26
, Luísa Polo-Silveira, MD, MPH a, Isabella Dana, BS a, Viviane Liao, BS a, Maria Josefina Lorenzoni, MD b, Miguel Cordova, MD a, Stephen W. Dusza, DrPH a, Harold S. Rabinovitz, MD b, Cristian Navarrete-Dechent, MD c, Ashfaq A. Marghoob, MD aKey words : challenging solar lentigines (SLs), dermoscopy, small diameter lentigo maligna/lentigo maligna melanoma (small-LM/LMM)
Abbreviation used : HFO, LM/LMM, SL, SLs
| Funding sources: Supported in part by the National Institutes of Health / National Cancer Institute Cancer Center Support Grant P30 CA008748 . The funder played no role in any aspect of the study. |
|
| Patient consent: Not applicable. |
|
| IRB approval status: Reviewed and approved by Western IRB; approval 16-458. |
|
| This observational methodological study follows the STROBE reporting guidelines. |
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
